Published in
Elsevier, Leukemia Research, (111), p. 106737, 2021
DOI: 10.1016/j.leukres.2021.106737
Links
Tools
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
Journal article published in 2021 by
Jonathan A. Webster,
Tara M. Robinson 
,
Amanda L. Blackford ,
Erica Warlick,
Anna Ferguson,
Ivan Borrello,
Marianna Zahurak ,
Richard J. Jones,
B. Douglas Smith
,
Amanda L. Blackford ,
Erica Warlick,
Anna Ferguson,
Ivan Borrello,
Marianna Zahurak ,
Richard J. Jones,
B. Douglas Smith
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 